PharmEnable Tx

PharmEnable Therapeutics is reimagining small molecule drug discovery by harnessing AI to unlock the vastness of chemical space and deliver more effective medicines. 


Biology defines the challenge and chemSEEK™, our proprietary AI platform, designs the small molecule solution to treat it. By decoding the pharmacological needs of a target and exploring previously untapped chemical space, chemSEEK™ designs novel, diverse, and highly synthesisible molecules from first principles. Enabling access to data-sparse targets, chemSEEK™ accelerates the discovery of more effective medicines with superior selectivity and drug-like properties.


With an exciting pre-clinical pipeline of wholly-owned and partnered programs, we are harnessing chemSEEK™ to create first- and best-in-class small molecule medicines in areas of urgent medical need.

Address

Cambridge
United Kingdom
Loading